New Leaf Venture Partners
Venture capitalNew York · Seed–Late Stage · 7 people tracked
Also known as NEW LEAF VENTURE PARTNERS LLC
Find your way into New Leaf Venture Partners
733 people in our graph share verified history with the New Leaf Venture Partners team — schools, employers, funds. One of them is your warm intro.
Investment thesis
New Leaf Venture Partners is a venture capital firm investing in innovative healthcare companies.
Source: firm website, verified Sep 15, 2026.
Team · 7 people
from curated & public directories
Founder mafia
2 people who came through New Leaf Venture Partners went on to found or lead other companies.
What they invest in
from 26 of 29 portfolio companiesBiotech ×14Healthtech ×13Medical Devices ×5Digital Health ×4AI & Machine Learning ×3Consumer ×2SaaS ×2Data & Infrastructure ×1
HQs:United States×24Australia×1
Investments · 29 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 12024 · 22022 · 12019 · 12018 · 12017 · 32016 · 32015 · 22014 · 217 dated
iRhythm provides wearable cardiac monitoring devices and AI-powered analysis services for clinicians to diagnose heart arrhythmias.
AI & Machine LearningHealthtechMedical DevicesSan Francisco, US
Kevin M. King(Executive Officer, Director)inShelly D. Guyer(Executive Officer)inWilliam F. Willis(Executive Officer, Director)Judith Lenane(Executive Officer)Steve Johnson(Executive Officer)in
BoardTiba Aynechi(Director)in
Board seatVijay Lathi· per SEC Form D · $29.5M raise · filed Mar 2015
Co-investorsKaiser Permanente VenturesNorwest Venture PartnersSt. Jude Medical
Passage Bio is a biotechnology company developing treatments for central nervous system (CNS) diseases, with a focus on neurodegenerative conditions.
BiotechHealthtechPhiladelphia, US
William Chou(Chief Executive Officer)Tadataka Yamada(Executive Officer, Director, Promoter)Stephen Squinto(Executive Officer, Director)in
BoardPatrick Heron(Director)inCarl Gordon(Director)inThomas Street Address 1 Woiwode(Director)
Co-investorsFrazier Life SciencesAccess BiotechnologyFrazier Healthcare PartnersOrbiMedVersant VenturesVivo Capital
CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.
BiotechHealthtech
Anthony Fordin
Co-investorsAlta PartnersLongitude Capitalabrdn plcIntermediate Capital GroupJohnson & Johnson Innovation – JJDCPappas Capital+2 more
Real-time asset tracking and workflow monitoring in healthcare
San Diego, US
Brandon Hull(Director)Timothy Roche(Executive Officer, Director)Terry Linn(Director)Emily Wilson(Executive Officer)Paul Wallace(Director)Dana Mead(Director)
Board seatVijay Lathi· per SEC Form D · $1.9M raise · filed Aug 2017
Co-investorsIcon VenturesRex Health VenturesHERITAGE HEALTHCARE INNOVATIONKleiner PerkinsVenrock
Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease.
AI & Machine LearningDigital HealthHealthtechMedical DevicesDenver, US
James Min, MD(Founder)inJames K. Min(Executive Officer, Director)in
BoardLee Cooper(Director)Peter Justin Klein(Director)Scott Barclay(Director)inLouis Samson(Director)
Board seatVijay Lathi· per SEC Form D · $16.8M raise · filed Mar 2022
Co-investorsBattery VenturesBreyer CapitalDigiTx Partners LLCInsight PartnersLRVHealthPura Vida Investments+3 more
Barricaid develops a bone-anchored implant designed to reduce reherniation and reoperation in patients undergoing discectomy for large annular defects.
HealthtechMedical DevicesWoburn, US
Gregory H. Lambrecht(Director)Carey Hagan(Executive Officer, Director)Cary Hagan(Executive Officer, Director)
BoardRyan Drant(Director)inJoshua Makower(Director)
Board seatJeani Delagardelle· per SEC Form D · $7.5M raise · filed Apr 2023
Co-investorsDelos CapitalNew Enterprise Associates (NEA)Questa CapitalGreenspring Associates
Bluesight provides software solutions for hospital and pharmacy operations, including inventory management, drug diversion monitoring, purchasing optimization, and compliance tools.
AI & Machine LearningEnterprise SoftwareHealthtechWashington, US
Kevin MacDonald(Executive Officer)inTimothy Kress-Spatz(Executive Officer)
Board seatVijay Lathi· per SEC Form D · filed Jun 2016
Co-investorsEaston CapitalKaiser Permanente VenturesLionBirdRex Health VenturesRock Health
Kyruus Health provides a healthcare access platform that unifies provider and member data to help patients find, schedule, and access care.
Digital HealthHealthtechSaaSBoston, US
Graham Gardner(Executive Officer, Director)inJulie Yoo(Executive Officer, Director)inGraham Gardner, MD, MBA(Founder)in
BoardRobert Paull(Director)inRobert Higgins(Director)Bryan Roberts(Director)
Board seatVijay Lathi· per SEC Form D
Co-investorsF-Prime CapitalFrancisco PartnersTRANSFORMATION CAPITALVenrockHighland Capital PartnersLux Capital+1 more
Truveris offers a technology platform with claims analytics and PBM (pharmacy benefit manager) oversight to reduce pharmacy benefit costs through contract optimization for employers.
Data & InfrastructureDigital HealthHealthtechSaaSNew York, US
Anthony Joseph Loiacono(Executive Vice-President, Sales and Marketing)Michael Facendola(Executive Officer)inLouise Shea(Chief Pharmacy Officer)inBryan Birch(Chief Executive Officer)in
BoardPhilippe Chambon(Director)Stephen M. Bloch(Director)in
Board seatVijay Lathi· per SEC Form D
Co-investorsCanaan PartnersMcKesson VenturesNAV.VCTribeca Venture Partners
Abcuro develops therapies that target highly cytotoxic T cells for autoimmune diseases, including its lead candidate ulviprubart for inclusion body myositis.
BiotechHealthtechNewton, US
Steven A. Greenberg(Chief Scientific Advisor & Co-Founder)Steven A. Greenberg, MD(Chief Scientific Advisor & Co-Founder)John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Evan Thompson(Executive Officer)David de Graaf(Executive Officer, Director)
Co-investorsBain Capital Life SciencesNew Enterprise Associates (NEA)RA CapitalSamsara BioCapitalSanofi VenturesMass General Brigham Ventures+8 more
BiotechSan Carlos, US
Anthony P. Ford(Executive Officer, Director)inBenjamin Potter(Executive Officer)Henry Skinner(Director)Liam Ratcliffe(Director)in
BoardRon Hunt(Director)inLoretta Tse, Ph.D.(Director)
Co-investorsAlta Partners
Deciphera is a pharmaceutical company focused on developing treatments for people living with cancer.
Biotech
Daniel Flynn(Founder)in
Co-investorsFrazier Life SciencesREDMILEViking Global Investors
Dimension Therapeutics was a Cambridge, Massachusetts biopharmaceutical company developing AAV-based gene therapies for rare liver-associated metabolic diseases like hemophilia, OTC deficiency, and glycogen storage disease.
Cambridge, US
Annalisa Jenkins(Executive Officer, Director)
BoardBenjamin Auspitz(Director)Donald J. Hayden(Director)Allan Fox(Director)
Co-investorsF-Prime CapitalOrbiMed
Flosonics Medical makes FloPatch, a wireless wearable Doppler ultrasound device that assesses a patient's carotid arterial pulse in real time to give clinicians hemodynamic data for fluid resuscitation decisions.
Digital HealthHardwareMedical Devices
Joe Eibl(Founder)in
Co-investorsAmplify CapitalArboretum VenturesGenesys CapitaliGan PartnersRBCx
Cambridge, MA biotechnology company developing injectable synthetic biomarkers for noninvasive disease staging and treatment monitoring.
BiotechCambridge, US
Gabriel Kwong(Executive Officer)inSangeeta BhatiainRoopom Banerjee(Executive Officer)in
BoardTheresia Gouw(Director)inAmy Schulman(Director)inStan Lapidus(Director)in
Co-investorsGreatPoint VenturesAcrew CapitalAspect VenturesCatalio Capital ManagementDns CapitalPolaris Partners+2 more
A research-intensive biopharmaceutical company that develops medicines and vaccines.
BiotechHealthtechSouth San Francisco, US
Luke Nathaniel Walker(Executive Officer)Julie Eastland(Executive Officer, Director)in
BoardRonald Hunt(Director)Mark Chin(Director)Alan Colowick(Director)Jonathan Drachman(Director)
Co-investorsK2 HealthVenturesTaiho Ventures, LLCArix BioscienceLilly Asia VenturesMPM BioImpactOrbiMed
Kit is a pocket money app and debit card built by CommBank for children to earn pocket money, save towards goals, and track spending, while parents monitor spending, set limits, and manage multiple children's accounts.
ConsumerEdTechFintechAustralia, AU
Co-investorsx15ventures (Commonwealth Bank)Kaiser Permanente VenturesSands Capital Ventures
BiotechSan Francisco, US
Philip Fung(Executive Officer, Director)
BoardRoberto Sanabria(Director)in
Co-investorsExpaEaston Capital Investment GroupKaiser Permanente VenturesLionBirdSands Capital Ventures
BiotechSouth San Francisco, US
MARTIN BABLER(Executive Officer, Director)in
BoardPETER THOMPSON(Director)inSRINIVAS AKKARAJU(Director)MICHAEL DYBBS(Director)inSIMEON GEORGE(Director)LEWIS J. SHUSTER(Director)
Co-investorsAccess BiotechnologyMission BiocapitalSofinnova VenturesMission Bay CapitalOrbiMedSamsara BioCapital
Qlaris Bio is a clinical-stage biotechnology company developing therapies for ophthalmology conditions.
BiotechMedical DevicesDedham, US
Thurein Htoo(Executive Officer, Director)inFred Guerard(President & Chief Executive Officer)inBarbara Wirostko(Executive Officer)
BoardWende Hutton(Director)inRonald M. Hunt(Director)Andrew Danielson(Director)
Co-investorsCanaan Partnersabrdn plcCorrelation VenturesMayo Clinic Ventures
BiotechGreenwhich, US
Wendy DiCicco(Ms. DiCicco is the Secretary and Treasurer of the Issuer.)inArthur Feldman(Director)Magdalene Cook(Executive Officer, Director)Campbell Murray(Director)Edward J. Benz, Jr.(Director)Thomas Needham(Director)in
Co-investorsBioAdvanceElysia CapitalBroadview VenturesInnogest CapitalNovartis Venture Fund
Reviral operates an affiliate review site that ranks and reviews online casinos not registered with the UK's GamStop self-exclusion scheme, comparing licences, bonuses, wagering terms, payout speeds, and payment methods.
ConsumerMedia & Entertainment
Co-investorsAndera PartnersBrace PharmaOrbiMedWellcome Trust
Star Therapeutics develops treatments aimed at addressing real-world patient needs.
BiotechSouth San Francisco, US
Adam Rosenthal(Founder & CEO)inNancy Stagliano(Director)inMichelle Carpenter(Executive Officer)Sandip Panicker(Executive Officer)Scott Robertson(Executive Officer)inGary Patou(Executive Officer)in
Co-investorsFrazier Life SciencesOrbiMedRA CapitalSanofi VenturesSofinnova VenturesAgent Capital+8 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AIC Innovations GroupReshape MedicalBenefit SolutionsBraeburn PharmaceuticalsCardioKinetixDirect Flow Medical
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 5
2 IPOs · 3 acquisitions · showing 4IrhythmtechNASDAQ: IRTCPassage BioNASDAQ: PASGAwarepointacq. by CenTrakDimension Therapeuticsacq. by Ultragenyx Pharmaceutical
Portfolio news
latest coverage across their companies
Abcuro · clinicaltrialsarena.com · Aug 19, 2026
Passage Bio · stocktitan.net · Aug 10, 2026
Star Therapeutics · pharmaceutical-technology.com · Oct 1, 2025
Kyruus · mobihealthnews.com · Sep 24, 2025
Frequently asked questions
- How many investments has New Leaf Venture Partners made?
- New Leaf Venture Partners has 29 tracked investments, 5 of which have exited, including 2 dated in the last 24 months.
- What stage does New Leaf Venture Partners invest at?
- New Leaf Venture Partners invests at the Seed, Series A, Series B, Late Stage stages.
- What sectors does New Leaf Venture Partners focus on?
- New Leaf Venture Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is New Leaf Venture Partners located?
- New Leaf Venture Partners is headquartered in New York, US.
Co-investors · 19
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
RA Capital is a multi-stage investment firm focused on healthcare, life sciences, and planetary health, investing across public and private markets and creating new companies through its Raven incubation platform.
SV Health Investors is a healthcare-focused investment firm that invests across multiple stages, geographies and healthcare sectors.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Versant Ventures operates in-house Discovery Engines staffed by multidisciplinary scientists in dedicated laboratory facilities to help launch new biotechnology companies alongside academic founders.
Johnson & Johnson Innovation is the innovation arm of Johnson & Johnson, working to advance life science innovation through early partnerships, incubation via JLABS, venture investing through JJDC, and late-stage partnerships to address global health challenges.
Frazier Healthcare Partners is a healthcare-focused private equity firm that partners with profitable, growing healthcare companies to drive scale and long-term value, pairing high-conviction investment themes with experienced executives.
Bain Capital Life Sciences, founded in 2016, invests in biopharmaceutical, medical device, diagnostic, and life science tool companies globally, focusing on companies addressing unmet medical needs and driving medical innovation.
Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.
Goodwater Capital is a consumer technology investment firm backing entrepreneurs building companies across sectors such as housing, healthcare, food delivery, financial services, education, entertainment, and transportation.
Wildcat Venture Partners is a venture capital firm that backs technology entrepreneurs aiming to create new market categories.
▶7 more co-investors
GE Ventures5AM VenturesDomain AssociatesNextech InvestLightstone VenturesVantagePoint Capital Partners4see Ventures
Firms observed investing alongside New Leaf Venture Partners, from public investor directories. Shared companies are the overlap with New Leaf Venture Partners's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
T. Rowe Price is a global asset management firm that actively invests across markets to pursue opportunities on behalf of its clients.
The JDRF T1D Fund is a venture philanthropy investor focused on type 1 diabetes (T1D), backing companies developing disease-modifying therapies and cures for the condition.
New Alliance Capital is a Shanghai-based private equity and venture capital firm founded in 2008, focused on technology-driven sectors. Its backers include state-owned enterprise groups, insurance capital, fund-of-funds, government guidance funds, and listed companies.